{
    "table_id": "finqa_531f90ae93",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "INTC/2018/page_105.pdf-1",
        "pre_text_caption_evidence": [
            "assets measured and recorded at fair value on a non-recurring basis our non-marketable equity securities , equity method investments , and certain non-financial assets , such as intangible assets and property , plant and equipment , are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period .",
            "if an impairment or observable price adjustment is recognized on our non-marketable equity securities during the period , we classify these assets as level 3 within the fair value hierarchy based on the nature of the fair value inputs .",
            "we classified non-marketable equity securities and non-marketable equity method investments as level 3 .",
            "impairments recognized on these investments held as of december 29 , 2018 were $ 416 million ( $ 537 million held as of december 30 , 2017 and $ 153 million held as of december 31 , 2016 ) .",
            "financial instruments not recorded at fair value on a recurring basis financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period , grants receivable , loans receivable , reverse repurchase agreements , and our short-term and long-term debt .",
            "prior to the adoption of the new financial instrument standard , our non-marketable cost method investments were disclosed at fair value on a recurring basis .",
            "the carrying amount and fair value of our non-marketable cost method investments as of december 30 , 2017 were $ 2.6 billion and $ 3.6 billion , respectively .",
            "these measures are classified as level 3 within the fair value hierarchy based on the nature of the fair value inputs .",
            "as of december 29 , 2018 , the aggregate carrying value of grants receivable , loans receivable , and reverse repurchase agreements was $ 833 million ( the aggregate carrying amount as of december 30 , 2017 was $ 935 million ) .",
            "the estimated fair value of these financial instruments approximates their carrying value and is categorized as level 2 within the fair value hierarchy based on the nature of the fair value inputs .",
            "for information related to the fair value of our short-term and long-term debt , see 201cnote 15 : borrowings . 201d note 17 : other comprehensive income ( loss ) the changes in accumulated other comprehensive income ( loss ) by component and related tax effects for each period were as follows : ( in millions ) unrealized holding ( losses ) on available-for -sale equity investments unrealized holding ( losses ) on derivatives actuarial valuation and other pension expenses translation adjustments and other total ."
        ],
        "question": "what is the net change in the accumulated other comprehensive income during 2017?"
    },
    "dimensions": {
        "rows": 13,
        "columns": 6
    },
    "schema": {
        "columns": [
            "( in millions )",
            "unrealized holding gains ( losses ) on available-for-sale equity investments",
            "unrealized holding gains ( losses ) on derivatives",
            "actuarial valuation and other pension expenses",
            "translation adjustments and other",
            "total"
        ],
        "dtypes": {
            "( in millions )": "object",
            "unrealized holding gains ( losses ) on available-for-sale equity investments": "object",
            "unrealized holding gains ( losses ) on derivatives": "object",
            "actuarial valuation and other pension expenses": "object",
            "translation adjustments and other": "object",
            "total": "object"
        }
    }
}